As CEO of ValSource, Ms. Kutney oversees all business operations. She has nearly 20 years of experience in the pharmaceutical, medical device, and biotech fields encompassing execution activities, management of complex projects, and business oversight. Ms. Kutney holds a Chemical Engineering degree from the University of Notre Dame.

Hal Baseman is Vice President and Director at ValSource Inc. He has over 40 years of experience in pharmaceutical operations, validation, and regulatory compliance. He has held positions in executive management and technical operations at several drug manufacturing and consulting firms. He is the former chair of the PDA Board of Directors, former chair of the PDA Science Advisory Board, former co-leader of the PDA Process Validation Interest Group, and co-leader of the PDA Aseptic Processing Points to Consider and Annex 1 Commenting Task Forces, as well as a long-time member of the PDA Training Research Institute faculty. Baseman holds an MBA in management from LaSalle University and a B.S. in biology from Ursinus College.

Ms. White joined ValSource in 2012. Her responsibilities include assisting in performing all tasks necessary to achieve the organization’s mission and growth plans as part of the management team. She also is responsible for preparing and overseeing fiscal reporting activities as well as analyze and build financial records to improve and accurately report the Company’s financial position.

Mr. Calvaresi is the founder of ValSource. He has over 30 years of experience related to the operation and validation of pharmaceutical facilities. This includes three years of operational experience supervising manufacturing and process development at a major biotechnology company.

As Vice President of Business Operations at ValSource, Mr. Taormina oversees all commissioning, qualification and validation (CQV) regions across the US. He has over 23 years of experience in the pharmaceutical and biotech fields, encompassing all CQV activities, management of complex projects, and business oversight.

Matteo has spent 20 years dedicated to ValSource and has been promoted from Validation Engineer to Project Manager, then Regional Manager, and now VP of Business Operations. He holds a Biology degree, with a minor in Chemistry from Fitchburg State University.

Brian Jordan is the Vice President of Business Development for ValSource. Brian has been with ValSource for more than 25 years and has been in the pharmaceutical, biotech and medical device industries for over 30 years.

Brian’s responsibilities include identifying and developing new business prospects for ValSource throughout the US. Brian leads a team of people in researching and building relationships with new clients. In addition, Brian has extensive, direct experience in the commissioning, qualification, and validation (CQV) of utility, laboratory, process, and control systems.

Hal Baseman:
Hal Baseman is the Chief Operating Officer and a Director at ValSource Inc. He has over 40 years of experience in pharmaceutical operations, validation, and regulatory compliance. He has held positions in executive management and technical operations at several drug manufacturing and consulting firms. He is the former chair of the PDA Board of Directors, former chair of the PDA Science Advisory Board, former co-leader of the PDA Process Validation Interest Group, and co-leader of the PDA Aseptic Processing Points to Consider and Annex 1 Commenting Task Forces, as well as a long-time member of the PDA Training Research Institute faculty.

David Calvaresi:

Mr. Calvaresi is the founder of ValSource. He has over 30 years of experience related to the operation and validation of pharmaceutical facilities. This includes three years of operational experience supervising manufacturing and process development at a major biotechnology company.

Diane Blumenthal:

Diane joins the ValSource board of directors with more than 35 years of experience in biopharmaceutical process and product development, clinical and commercial manufacturing, quality control, scientific facilities, program management, and CMC regulatory. Former SVP/Head of Technical Operations at Spark Therapeutics, Ms. Blumenthal is skilled in building and transitioning companies from a start-up research and development organization to a fully integrated biopharmaceutical company with approved commercial manufacturing operations and products. Throughout her career, Ms. Blumenthal has played a key role in the development and commercialization of several well-known pharmaceutical products.

Katherine Oates:

Katherine brings over 25 years of human resources executive experience to the board of directors at ValSource. Ms. Oates is currently the VP of Human Resources for GlaxoSmithKline’s US Pharmaceuticals business. Throughout Ms. Oates’ career with GSK, she has worked with multiple businesses in a variety of HR leadership roles. Ms. Oates’ primary focus throughout her career has been enhancing organizational effectiveness through talent management, workforce engagement, leadership development, and culture.

Robert Radie:

Robert joins the ValSource board of directors with three decades of experience working in both public and private pharmaceutical and biotech companies, and across a range of therapeutic areas. Mr. Radie is currently the Chairman of the Board and CEO at Neuraptive Therapeutics, he has also held senior executive positions in six companies, including serving as Chief Executive Officer of Zyla Life Sciences, Inc. Transmolecular Inc, and Topaz Pharmaceuticals, Inc., which was acquired by Sanofi Pasteur. Mr. Radie also currently serves on the board of directors of several companies, including Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), and Rockwell Medical Technologies Inc. (NASDAQ: RMTI).